Balchem Corp (BCPC)
120.52
+1.82 (+1.53%)
USD |
NASDAQ |
May 20, 16:00
120.56
+0.04 (+0.03%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.879B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -6.56% |
| Valuation | |
| PE Ratio | 40.85 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.928 |
| Price to Book Value | 4.423 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.64 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.1238 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.70% |
News
Headline
Wire
Time (ET)
Yahoo
05/10 13:14
MT Newswires
05/02 08:18
MT Newswires
04/29 07:00
MT Newswires
04/29 07:00
Globe Newswire
04/29 07:00
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 07/29/2022* | -- | Results | Q2 2022 | -- | 1.00 | -- | |
| 07/29/2022* | 11:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 04/29/2022 | -- | Results | Q1 2022 | 1.03 | 0.92 | 11.96% | |
| 04/29/2022 | 11:00 EST | Earnings Call | Q1 2022 | -- | -- | -- | |
| 02/18/2022 | -- | Results | Q4 2021 | 0.85 | 0.85 | 0.00% | |
| 02/18/2022 | 11:00 EST | Earnings Call | Q4 2021 | -- | -- | -- | |
| 10/29/2021 | -- | Results | Q3 2021 | 0.92 | 0.94 | -1.60% | |
| 10/29/2021 | 11:00 EST | Earnings Call | Q3 2021 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New York |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Jul. 29, 2022 (est.) |
| Last Earnings Release | Apr. 29, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 27, 2021 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.64 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.4007 |
| Yield to Sector | 0.1145 |
| Yield to Industry | 0.1976 |
| Last Dividend Amt. | 0.64 |
| Dividend Frequency | Annually |
| Last Ex-Dividend Date | Dec. 27, 2021 |
| Yield (TTM) | 0.53% |
| Forward Yield | 0.53% |
| Payout Ratio | 19.48% |
| Cash Payout Ratio | 15.21% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk Info
Total Returns Comparison
Annual Total Returns Versus Peers
As of May 20, 2022.
Fundamentals
| Revenue (TTM) | 799.02M |
| Total Expenses (TTM) | 671.52M |
| Net Income (TTM) | 96.10M |
| Total Assets (Quarterly) | 1.199B |
| Total Liabilities (Quarterly) | 322.31M |
| Shareholders Equity (Quarterly) | 877.02M |
| Cash from Operations (TTM) | 160.51M |
| Cash from Investing (TTM) | -35.30M |
| Cash from Financing (TTM) | -102.18M |
Ratings
Profile
Edit
| Balchem manufactures ingredients, nutrients, and chemicals for a wide variety of industries, including human nutrition, animal nutrition, and oil and gas. The company offers a wide variety of product lines, with some highly customized and others commodity-oriented. After the 2014 acquisition of SensoryEffects, the human nutrition and health segment now generates the largest share of companywide revenue and profits. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New York |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Jul. 29, 2022 (est.) |
| Last Earnings Release | Apr. 29, 2022 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 27, 2021 |
Risk Info
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| WIGRX | 82.32M USD | 2.33% |
| CCASX | 88.53M USD | 2.28% |
| NWKBX | 29.53M USD | 2.26% |
| WGMCX | 42.07M USD | 1.93% |
| SLYG | 19.00M USD | 0.96% |
| IJT | 45.61M USD | 0.94% |
| SLY | 7.243M USD | 0.44% |
| SPSM | 18.11M USD | 0.44% |
| VSMSX | 18.72M USD | 0.44% |
| IJR | 269.93M USD | 0.43% |
| VIOO | 16.69M USD | 0.43% |
| VTSIX | 34.81M USD | 0.42% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Morningstar | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| BCPC Tweets |